181 result(s) found
Are These 3 Cheap Dividend Stocks With High Yields Too Good to Be True?
https://www.fool.com/investing/2023/12/14/are-these-3-cheap-dividend-stocks-with-high-yields/?source=iedfolrf0000001
Dec 14, 2023 - The highest-yielding stock on this list pays 7.7%.
0
Billionaire Investor Is Buying Big Dividends: Altria And AT&T
https://seekingalpha.com/article/4658275-billionaire-investor-is-buying-big-dividends-altria-and-at-and-t?source=feed
Dec 18, 2023 - Ray Dalio’s principles provide valuable lessons for investors seeking to cultivate financial success. Find out 2 excellent dividend payers he is buying.
0
Rayonier declares $0.20 special dividend; $0.20 a operating partnership unit
https://seekingalpha.com/news/4047766-rayonier-declares-020-special-dividend?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Dec 18, 2023 - Rayonier (RYN) declares $0.20/share special dividend. "The company also announced today that the company’s board of directors, in its capacity as the board of t
0
Will 2024 bring good tidings to media and telecom companies? That's unlikely
https://www.cnbc.com/2023/12/19/media-telecom-companies-face-rough-2024.html
Dec 19, 2023 - It's human nature to be optimistic entering a new year, but it's hard not to view 2024 as a year of uncertainty for media and telecommunications companies.
0
AT&T Stock Is a Buy for This Reason
https://www.fool.com/investing/2023/12/24/att-stock-is-a-buy-for-this-reason/?source=iedfolrf0000001
Dec 24, 2023 - Investors have good reason to pay more attention to one particular metric.
0
Oncternal slips after early data for lymphoma therapy
https://seekingalpha.com/news/4050320-oncternal-stock-slips-lymphoma-drug-data?source=feed_sector_healthcare
Dec 26, 2023 - Oncternal Therapeutics (ONCT) shares fell in reaction to initial results from its Phase 1/2 study for CAR T cell therapy in B-cell lymphoma. Read more here.
0
TCAF: A Promising Active Fund
https://seekingalpha.com/article/4659892-tcaf-promising-active-fund?source=feed_tag_etf_portfolio_strategy
Dec 27, 2023 - T. Rowe Price Capital Appreciation Equity ETF (TCAF) has seen significant growth, amassing over $600M in AUM in less than 6 months. Read more here.
0
M&T Bank Corporation (MTB) Q4 2023 Earnings Call Transcript
https://seekingalpha.com/article/4663611-m-and-t-bank-corporation-mtb-q4-2023-earnings-call-transcript?source=feed_sector_transcripts
Jan 18, 2024 - M&T Bank Corporation (NYSE:NYSE:MTB) Q4 2023 Earnings Conference Call January 18, 2024 8:00 AM ETCompany ParticipantsBrian Klock - Investor...
0
BILS: A Place To Park Cash To Pay The Bills
https://seekingalpha.com/article/4663613-bils-a-place-to-park-cash-to-pay-the-bills?source=feed_tag_etf_portfolio_strategy
Jan 18, 2024 - SPDR Bloomberg 3-12 Month T-Bill ETF has a slightly lower performance compared to the index due to its annual expense ratio. Read more about BILS.
0
SA Analysts Comment On FDA Seeking Boxed Warning For CAR-T Cancer Therapies, Related Impact On AUTL
https://seekingalpha.com/article/4664405-sa-analysts-comment-on-fda-seeking-boxed-warning-for-car-t-cancer-therapies-related-impact-on-autl?source=feed_tag_editors_picks
Jan 23, 2024 - SA Analysts comment on FDA seeking 'Boxed Warning' for CAR-T cancer therapies, and the related impact on Autolus Therapeutics.
0